From: Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumab
HER2 status
Fisher’s exact p
Positive
Negative
N
%
TOP2A (FISH) n=221
Amplified
55
41.0
0
<0.001
Deleted
21
15.7
5
5.7
Non-amplified
58
43.3
82
94.3
TopoIIa (IHC) n=193
39
33.9
29
37.2
0.65
76
66.1
49
62.8